Search Results 621-630 of 16879 for Amphotericin B
... B-. Cancer. Mayo Clinic prepares to biomanufacture a new CAR-T cell therapy for recurring B-cell blood cancers. Susan Buckles. October 10, 2023. Preparing to ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study ...
Sumera I. Ilyas, M.B.B.S.. Transplant Hepatologist. Rochester, MN. Areas of focus: Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B ...
... B-. Cancer. Mayo Clinic prepares to biomanufacture a new CAR-T cell therapy for recurring B-cell blood cancers. Latest stories. World Cancer Day: Making a ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Jeffrey B. Jensen, M.D.. Critical Care Specialist; Anesthesiologist ; John Joerns, M.D.. Internist; Critical Care Specialist; Transplant Pulmonologist ; Pete F.
Other Medical Problems · Diabetes or · Heart or blood vessel disease or · Hepatitis B, history of or · Hepatitis C, history of or · Herpes zoster infection or · HIV ...
B., M.P.H.. Colon and Rectal Surgeon. Rochester, MN. Areas of focus: Colorectal surgery, Rectal cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.